Cargando…

Corticosteroid Therapy in Severe Cases of Pneumonia Caused by SARS-CoV-2

We present a case of severe pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a 63-year-old woman needing venous oxygenation by an extracorporeal membrane. Given the difficult clinical resolution with persistent inflammatory parameters, treatment with corticosteroid...

Descripción completa

Detalles Bibliográficos
Autores principales: Alves, João, Salgueiro, Andrea, Baptista, João Pedro, Martins, Paulo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883672/
https://www.ncbi.nlm.nih.gov/pubmed/36721548
http://dx.doi.org/10.7759/cureus.33076
_version_ 1784879555057549312
author Alves, João
Salgueiro, Andrea
Baptista, João Pedro
Martins, Paulo
author_facet Alves, João
Salgueiro, Andrea
Baptista, João Pedro
Martins, Paulo
author_sort Alves, João
collection PubMed
description We present a case of severe pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a 63-year-old woman needing venous oxygenation by an extracorporeal membrane. Given the difficult clinical resolution with persistent inflammatory parameters, treatment with corticosteroids (methylprednisolone) was prescribed. The clinical evolution observed, namely the improvement of respiratory and imaging parameters, reiterates the recommendations of corticosteroids for moderate to severe disease.
format Online
Article
Text
id pubmed-9883672
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-98836722023-01-30 Corticosteroid Therapy in Severe Cases of Pneumonia Caused by SARS-CoV-2 Alves, João Salgueiro, Andrea Baptista, João Pedro Martins, Paulo Cureus Emergency Medicine We present a case of severe pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a 63-year-old woman needing venous oxygenation by an extracorporeal membrane. Given the difficult clinical resolution with persistent inflammatory parameters, treatment with corticosteroids (methylprednisolone) was prescribed. The clinical evolution observed, namely the improvement of respiratory and imaging parameters, reiterates the recommendations of corticosteroids for moderate to severe disease. Cureus 2022-12-29 /pmc/articles/PMC9883672/ /pubmed/36721548 http://dx.doi.org/10.7759/cureus.33076 Text en Copyright © 2022, Alves et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Emergency Medicine
Alves, João
Salgueiro, Andrea
Baptista, João Pedro
Martins, Paulo
Corticosteroid Therapy in Severe Cases of Pneumonia Caused by SARS-CoV-2
title Corticosteroid Therapy in Severe Cases of Pneumonia Caused by SARS-CoV-2
title_full Corticosteroid Therapy in Severe Cases of Pneumonia Caused by SARS-CoV-2
title_fullStr Corticosteroid Therapy in Severe Cases of Pneumonia Caused by SARS-CoV-2
title_full_unstemmed Corticosteroid Therapy in Severe Cases of Pneumonia Caused by SARS-CoV-2
title_short Corticosteroid Therapy in Severe Cases of Pneumonia Caused by SARS-CoV-2
title_sort corticosteroid therapy in severe cases of pneumonia caused by sars-cov-2
topic Emergency Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883672/
https://www.ncbi.nlm.nih.gov/pubmed/36721548
http://dx.doi.org/10.7759/cureus.33076
work_keys_str_mv AT alvesjoao corticosteroidtherapyinseverecasesofpneumoniacausedbysarscov2
AT salgueiroandrea corticosteroidtherapyinseverecasesofpneumoniacausedbysarscov2
AT baptistajoaopedro corticosteroidtherapyinseverecasesofpneumoniacausedbysarscov2
AT martinspaulo corticosteroidtherapyinseverecasesofpneumoniacausedbysarscov2